Biotechnology
601 companies in this industry
Insider Buys (30d)
54
$213.56M
Insider Sells (30d)
287
$529.16M
Top Companies by Market Cap
VRTXVertex Pharmaceuticals Incorporated
$128.10BREGNRegeneron Pharmaceuticals, Inc.
$75.74BMRNAModerna, Inc.
$75.39BARGXargenx SE
$45.82BRVMDRevolution Medicines, Inc.
$43.93BALNYAlnylam Pharmaceuticals, Inc.
$29.40BROIVRoivant Sciences Ltd.
$25.80BBNTXBioNTech SE
$24.56BINSMInsmed Incorporated
$24.09BINCYIncyte Corporation
$23.37BRecent Insider Trades
| Date | Ticker | Company | Insider | Role | Type | Shares | Avg Price | Value |
|---|---|---|---|---|---|---|---|---|
| Oct 9, 2026 | PYXS | Pyxis Oncology, Inc. | GordonMD Global Investments LP | 10 percent owner | Buy | 7,172,000 | $3.50 | $25.10M |
| Oct 9, 2026 | UTHR | United Therapeutics Corporation | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,300 | $534.50 | $4.97M |
| Oct 9, 2026 | IMVT | Immunovant, Inc. | Van Tuyl Christopher | officer: Chief Legal Officer | Sell | 1,327 | $32.06 | $42.5K |
| Oct 9, 2026 | PTCT | PTC Therapeutics, Inc. | SCHMERTZLER MICHAEL | director | Sell | 2,500 | $63.39 | $158.5K |
| Oct 9, 2026 | IMVT | Immunovant, Inc. | Gloria Melanie | officer: Chief Operating Officer | Sell | 2,241 | $32.06 | $71.8K |
| Oct 9, 2026 | IMVT | Immunovant, Inc. | Stout Jay S | officer: Chief Technology Officer | Sell | 3,809 | $32.06 | $122.1K |
| Oct 9, 2026 | ZYME | Zymeworks Inc. | Schayowitz Adam | officer: EVP, Head of R&D | Sell | 13,832 | $25.85 | $357.6K |
| Oct 8, 2026 | RAPP | Rapport Therapeutics, Inc. Common Stock | Ceesay Abraham | director, officer: Chief Executive Officer | Sell | 4,522 | $31.68 | $143.3K |
| Oct 8, 2026 | RLAY | Relay Therapeutics, Inc. | Patel Sanjiv | director, officer: President and CEO | Sell | 48,199 | $18.10 | $872.4K |
| Oct 8, 2026 | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | officer: Chief Financial Officer | Sell | 17,717 | $18.59 | $329.3K |
| Oct 8, 2026 | UTHR | United Therapeutics Corporation | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $548.95 | $5.22M |
| Oct 8, 2026 | NRXS | NeurAxis, Inc. | Carrico Brian Allen | director, officer: Chief Executive Officer | Buy | 268 | $4.84 | $1.3K |
| Oct 8, 2026 | NRXS | NeurAxis, Inc. | Henrichs Timothy Robert | officer: Chief Financial Officer | Buy | 1,937 | $4.84 | $9.4K |
| Oct 8, 2026 | NRXS | NeurAxis, Inc. | Carrico Thomas Joeseph | officer: CRO, CCO, CPO | Buy | 328 | $4.84 | $1.6K |
| Oct 8, 2026 | IDYA | IDEAYA Biosciences, Inc. | Hata Yujiro S | director, officer: President and CEO | Sell | 26,338 | $37.41 | $985.4K |
| Oct 8, 2026 | ADPT | Adaptive Biotechnologies Corporation | BOBULSKY SUSAN | officer: Chief Commercial Officer, MRD | Sell | 6,444 | $30.00 | $193.3K |
| Oct 8, 2026 | ADPT | Adaptive Biotechnologies Corporation | RUBINSTEIN JULIE | officer: President and COO | Sell | 35,643 | $26.60 | $948.2K |
| Oct 8, 2026 | HALO | Halozyme Therapeutics, Inc. | Torley Helen | director, officer: PRESIDENT AND CEO | Sell | 60,000 | $110.18 | $6.61M |
| Oct 7, 2026 | DNA | Ginkgo Bioworks Holdings, Inc. | Coen Steven P. | officer: See remarks | Sell | 2,403 | $15.00 | $36.0K |
| Oct 7, 2026 | RXRX | Recursion Pharmaceuticals, Inc. | Borgeson Blake | director | Sell | 50,000 | $4.84 | $242.0K |
| Oct 7, 2026 | RXRX | Recursion Pharmaceuticals, Inc. | HERSHBERG ROBERT | director | Sell | 25,000 | $5.00 | $125.0K |
| Oct 7, 2026 | FDMT | 4D Molecular Therapeutics, Inc. | Kirn David | director, officer: See Remarks | Sell | 58,333 | $12.92 | $753.9K |
| Oct 7, 2026 | ARTV | Artiva Biotherapeutics, Inc. | Aslan Fred | director, officer: Chief Executive Officer | Sell | 23,463 | $7.20 | $168.9K |
| Oct 7, 2026 | PCVX | Vaxcyte, Inc. | Wassil Jim | officer: EVP, Chief Scientific Ofc, COO | Sell | 18,000 | $86.74 | $1.56M |
| Oct 7, 2026 | TWST | Twist Bioscience Corporation | Leproust Emily M. | director, officer: Chief Executive Officer | Sell | 4,548 | $202.15 | $919.4K |
| Oct 7, 2026 | PTCT | PTC Therapeutics, Inc. | Boulding Mark Elliott | officer: EXEC. VP AND CLO | Sell | 2,073 | $64.06 | $132.8K |
| Oct 7, 2026 | PCVX | Vaxcyte, Inc. | Cowan Elvia | officer: SVP, Finance & CAO | Sell | 19,000 | $86.74 | $1.65M |
| Oct 7, 2026 | ACRV | Acrivon Therapeutics, Inc. Common Stock | Miller Mary | officer: Chief Legal Officer | Sell | 294 | $1.99 | $585.06 |
| Oct 7, 2026 | AMLX | Amylyx Pharmaceuticals, Inc. | MILNE GEORGE M JR | director | Sell | 30,000 | $27.70 | $830.9K |
| Oct 7, 2026 | UTHR | United Therapeutics Corporation | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $538.67 | $5.12M |
| Oct 6, 2026 | ALNY | Alnylam Pharmaceuticals, Inc. | SUPRAN BRYAN | officer: EVP, CLO and Secretary | Sell | 1,758 | $226.88 | $398.9K |
| Oct 6, 2026 | IBRX | ImmunityBio, Inc. | Simon Barry J. | director | Sell | 25,000 | $10.75 | $268.8K |
| Oct 6, 2026 | IBRX | ImmunityBio, Inc. | Cohen Cheryl | director | Sell | 81,056 | $10.50 | $851.1K |
| Oct 6, 2026 | PTHS | Pelthos Therapeutics Inc. | Friedberg Ezra M | director | Sell | 558 | $20.72 | $11.6K |
| Oct 6, 2026 | NTLA | Intellia Therapeutics, Inc. | Dube Michael P | officer: VP, Chief Accounting Officer | Sell | 1,864 | $12.43 | $23.2K |
| Oct 6, 2026 | ARTV | Artiva Biotherapeutics, Inc. | Bush Jennifer | officer: COO, CLO, Compliance Officer | Sell | 8,370 | $6.84 | $57.2K |
| Oct 6, 2026 | OCUL | Ocular Therapeutix, Inc. | Heier Jeffrey S. | officer: Chief Scientific Officer | Sell | 10,869 | $7.05 | $76.6K |
| Oct 6, 2026 | ARTV | Artiva Biotherapeutics, Inc. | Banerjee Subhashis | officer: Chief Medical Officer | Sell | 1,099 | $6.84 | $7.5K |
| Oct 6, 2026 | OCUL | Ocular Therapeutix, Inc. | Kaiser Peter | officer: Chief Development Officer | Sell | 9,990 | $7.05 | $70.4K |
| Oct 6, 2026 | GLUE | Monte Rosa Therapeutics, Inc. | Bowen Matthew | officer: Principal Accounting Officer | Sell | 13 | $10.56 | $137.28 |
| Oct 6, 2026 | ARTV | Artiva Biotherapeutics, Inc. | Aslan Fred | director, officer: Chief Executive Officer | Sell | 61,696 | $6.84 | $421.8K |
| Oct 6, 2026 | DYN | Dyne Therapeutics, Inc. | Posner Brian S | director | Buy | 2,500 | $16.00 | $40.0K |
| Oct 6, 2026 | CYTK | Cytokinetics, Incorporated | Malik Fady Ibraham | officer: EVP Research & Development | Sell | 3,500 | $61.38 | $214.8K |
| Oct 6, 2026 | PTHS | Pelthos Therapeutics Inc. | Pauls Matthew | director | Sell | 786 | $21.00 | $16.5K |
| Oct 6, 2026 | PTHS | Pelthos Therapeutics Inc. | Greenleaf Peter | director | Sell | 797 | $21.17 | $16.9K |
| Oct 6, 2026 | LGND | Ligand Pharmaceuticals Incorporated | Reardon Andrew | officer: CLO & Secretary | Sell | 5,000 | $304.07 | $1.52M |
| Oct 6, 2026 | UTHR | United Therapeutics Corporation | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $541.64 | $5.15M |
| Oct 6, 2026 | ARTV | Artiva Biotherapeutics, Inc. | Horan Christopher | officer: Chief Tech Operations Officer | Sell | 10,340 | $6.84 | $70.7K |
| Oct 5, 2026 | ADPT | Adaptive Biotechnologies Corporation | RUBINSTEIN JULIE | officer: President and COO | Sell | 35,643 | $28.46 | $1.01M |
| Oct 5, 2026 | GRCE | Grace Therapeutics, Inc. | Opaleye Management Inc. | 10 percent owner | Buy | 60,490 | $2.05 | $123.8K |
Showing 1–50 of 341
1 / 7
...